rs74315373
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_006996.3(SLC19A2):c.484C>T(p.Arg162*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006996.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC19A2 | NM_006996.3 | c.484C>T | p.Arg162* | stop_gained | 2/6 | ENST00000236137.10 | NP_008927.1 | |
SLC19A2 | NM_001319667.1 | c.205-7292C>T | intron_variant | NP_001306596.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC19A2 | ENST00000236137.10 | c.484C>T | p.Arg162* | stop_gained | 2/6 | 1 | NM_006996.3 | ENSP00000236137.5 | ||
SLC19A2 | ENST00000367804.4 | c.205-7292C>T | intron_variant | 1 | ENSP00000356778.3 | |||||
SLC19A2 | ENST00000646596.1 | c.484C>T | p.Arg162* | stop_gained | 2/6 | ENSP00000494404.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251402Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135892
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461888Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 1999 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 13, 2023 | This sequence change creates a premature translational stop signal (p.Arg162*) in the SLC19A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC19A2 are known to be pathogenic (PMID: 10391221, 10391223, 10874303). This variant is present in population databases (rs74315373, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with thiamine-responsive megaloblastic anemia syndrome (PMID: 10391221). ClinVar contains an entry for this variant (Variation ID: 5955). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at